Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Adenocarcinoma × Tomography, X-Ray Computed × Clear all

Sponsor

Conditions

Prostatic Neoplasms 5 Lymphoma 3 Squamous Cell Carcinoma of Head and Neck 2 Melanoma 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Large B-Cell, Diffuse 2 Lung Neoplasms 2 Head and Neck Neoplasms 2 Carcinoma, Hepatocellular 2 Burkitt Lymphoma 2 Vasculitis 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Smoking Cessation 1 Small Cell Lung Carcinoma 1 Recurrence 1 Rectal Neoplasms 1 Osteomyelitis 1 Nose Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Pulmonary Nodules 1 Metastatic Solid Tumors 1 Lymphoproliferative Disorders 1 Lymphomatoid Granulomatosis 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Follicular 1 Liver Neoplasms 1 Heart Diseases 1

Interventions

Gemcitabine 11 Cisplatin 11 Capecitabine 11 Oxaliplatin 9 Fluorouracil 9 130-nm albumin-bound paclitaxel 8 pembrolizumab 7 Paclitaxel 7 Ramucirumab 6 Leucovorin 6 Carboplatin 6 Bevacizumab 6 Pemetrexed 4 Nivolumab 4 Irinotecan 4 Everolimus 4 Erlotinib Hydrochloride 4 Docetaxel 4 Cyclophosphamide 4 Albumin-Bound Paclitaxel 4 trastuzumab deruxtecan 3 Radiotherapy 3 Afatinib 3 zolbetuximab 2 pralsetinib 2 cabozantinib 2 Trastuzumab 2 Ipilimumab 2 vosaroxin 1 vandetanib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡